 Eileen Chang
Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetus | 14 | 2022 | 698 | 1.840 |
Why?
| | Ketamine | 5 | 2018 | 92 | 1.550 |
Why?
| | Placental Insufficiency | 4 | 2021 | 102 | 1.430 |
Why?
| | Fetal Hypoxia | 6 | 2018 | 49 | 1.430 |
Why?
| | Fetal Growth Retardation | 5 | 2021 | 470 | 1.300 |
Why?
| | Sheep | 19 | 2022 | 761 | 1.180 |
Why?
| | Muscle, Skeletal | 6 | 2022 | 1468 | 0.960 |
Why?
| | Muscle Development | 2 | 2021 | 99 | 0.830 |
Why?
| | Fetal Development | 2 | 2021 | 248 | 0.780 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 11 | 0.780 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 185 | 0.740 |
Why?
| | Amino Acids | 3 | 2022 | 445 | 0.710 |
Why?
| | Insulin-Like Growth Factor I | 4 | 2021 | 286 | 0.600 |
Why?
| | Insulin | 3 | 2021 | 2080 | 0.560 |
Why?
| | Cerebral Cortex | 2 | 2018 | 380 | 0.540 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2018 | 87 | 0.540 |
Why?
| | Hypoxia, Brain | 1 | 2016 | 10 | 0.530 |
Why?
| | Lower Extremity | 1 | 2019 | 334 | 0.520 |
Why?
| | Pregnancy | 14 | 2022 | 5499 | 0.520 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2016 | 128 | 0.490 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 102 | 0.490 |
Why?
| | Anesthetics, Dissociative | 1 | 2015 | 28 | 0.480 |
Why?
| | Hypoglycemic Agents | 1 | 2021 | 1011 | 0.450 |
Why?
| | Hydrocortisone | 2 | 2016 | 267 | 0.450 |
Why?
| | Hypoxia | 5 | 2020 | 956 | 0.450 |
Why?
| | Inflammation Mediators | 1 | 2016 | 475 | 0.420 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 445 | 0.410 |
Why?
| | Animals | 26 | 2022 | 31565 | 0.370 |
Why?
| | Hypothalamus | 3 | 2016 | 147 | 0.330 |
Why?
| | Kidney | 1 | 2015 | 1182 | 0.320 |
Why?
| | Pregnancy, Animal | 2 | 2019 | 52 | 0.300 |
Why?
| | Umbilical Cord | 2 | 2018 | 80 | 0.280 |
Why?
| | Gestational Age | 4 | 2021 | 761 | 0.270 |
Why?
| | Matrix Metalloproteinases | 3 | 2010 | 89 | 0.250 |
Why?
| | Female | 21 | 2022 | 59324 | 0.240 |
Why?
| | Islets of Langerhans | 2 | 2021 | 728 | 0.220 |
Why?
| | Ventricular Remodeling | 3 | 2010 | 224 | 0.220 |
Why?
| | Drug Administration Schedule | 2 | 2021 | 714 | 0.210 |
Why?
| | Transcriptome | 3 | 2018 | 723 | 0.200 |
Why?
| | Fetal Blood | 3 | 2021 | 268 | 0.200 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 45 | 0.190 |
Why?
| | Muscle Proteins | 2 | 2022 | 210 | 0.190 |
Why?
| | Placenta | 4 | 2021 | 628 | 0.190 |
Why?
| | Infusions, Intravenous | 1 | 2021 | 370 | 0.180 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 72 | 0.170 |
Why?
| | Alanine | 1 | 2019 | 105 | 0.160 |
Why?
| | Hindlimb | 1 | 2019 | 130 | 0.160 |
Why?
| | Sheep, Domestic | 2 | 2016 | 33 | 0.150 |
Why?
| | Coronary Vessels | 1 | 2020 | 234 | 0.150 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2017 | 61 | 0.140 |
Why?
| | Temperature | 1 | 2019 | 564 | 0.140 |
Why?
| | Staphylococcus | 1 | 2017 | 69 | 0.140 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 742 | 0.140 |
Why?
| | Ventricular Function, Left | 2 | 2010 | 477 | 0.140 |
Why?
| | Selection, Genetic | 2 | 2012 | 237 | 0.140 |
Why?
| | Gene Expression Profiling | 4 | 2016 | 1518 | 0.130 |
Why?
| | Triclosan | 1 | 2016 | 9 | 0.130 |
Why?
| | Mitochondria | 1 | 2021 | 744 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 449 | 0.130 |
Why?
| | Glucose | 1 | 2021 | 899 | 0.130 |
Why?
| | Anti-Infective Agents, Local | 1 | 2016 | 39 | 0.130 |
Why?
| | Endocrine Disruptors | 1 | 2016 | 34 | 0.130 |
Why?
| | Systems Biology | 1 | 2016 | 54 | 0.130 |
Why?
| | Oxidative Stress | 1 | 2021 | 1068 | 0.130 |
Why?
| | Pituitary Gland | 1 | 2016 | 147 | 0.120 |
Why?
| | Ischemia | 1 | 2018 | 361 | 0.120 |
Why?
| | Analgesics | 1 | 2016 | 156 | 0.120 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 180 | 0.120 |
Why?
| | Disease Models, Animal | 5 | 2016 | 3498 | 0.120 |
Why?
| | Saccharomyces cerevisiae | 2 | 2012 | 476 | 0.120 |
Why?
| | Chemokines | 1 | 2015 | 215 | 0.120 |
Why?
| | Brachiocephalic Trunk | 1 | 2014 | 11 | 0.120 |
Why?
| | RNA, Messenger | 3 | 2016 | 2550 | 0.110 |
Why?
| | Blood Pressure | 3 | 2016 | 1531 | 0.110 |
Why?
| | Interleukins | 1 | 2015 | 236 | 0.110 |
Why?
| | Endocrine System | 1 | 2013 | 19 | 0.110 |
Why?
| | Myosin Light Chains | 1 | 2012 | 26 | 0.100 |
Why?
| | Cardiac Myosins | 1 | 2012 | 26 | 0.100 |
Why?
| | Two-Hybrid System Techniques | 1 | 2012 | 52 | 0.100 |
Why?
| | Transcription Factors | 2 | 2014 | 1526 | 0.100 |
Why?
| | Molecular Biology | 1 | 2012 | 56 | 0.100 |
Why?
| | Immune System | 1 | 2013 | 171 | 0.100 |
Why?
| | Hemodynamics | 1 | 2016 | 1015 | 0.100 |
Why?
| | Cardiomegaly | 1 | 2012 | 158 | 0.100 |
Why?
| | Estradiol | 1 | 2014 | 450 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2012 | 318 | 0.090 |
Why?
| | Gene Expression | 1 | 2016 | 1417 | 0.090 |
Why?
| | Apoptosis | 1 | 2019 | 2349 | 0.090 |
Why?
| | Homeodomain Proteins | 1 | 2014 | 465 | 0.090 |
Why?
| | Heart Conduction System | 1 | 2010 | 80 | 0.080 |
Why?
| | Electric Stimulation Therapy | 1 | 2010 | 57 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 379 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2016 | 2322 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 484 | 0.080 |
Why?
| | Fibroblasts | 2 | 2010 | 834 | 0.080 |
Why?
| | Up-Regulation | 4 | 2014 | 802 | 0.080 |
Why?
| | Genomics | 1 | 2013 | 631 | 0.080 |
Why?
| | Brain | 2 | 2017 | 2355 | 0.080 |
Why?
| | Basigin | 1 | 2008 | 25 | 0.080 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2010 | 122 | 0.080 |
Why?
| | Time Factors | 2 | 2016 | 6077 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 282 | 0.070 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 683 | 0.070 |
Why?
| | Aorta, Thoracic | 1 | 2010 | 257 | 0.070 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2012 | 333 | 0.060 |
Why?
| | Oxygen | 2 | 2021 | 851 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2464 | 0.060 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2010 | 577 | 0.060 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2008 | 371 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 2010 | 787 | 0.060 |
Why?
| | Energy Metabolism | 2 | 2021 | 727 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2016 | 314 | 0.050 |
Why?
| | Genetic Complementation Test | 1 | 2003 | 62 | 0.050 |
Why?
| | Myocardial Infarction | 1 | 2010 | 932 | 0.050 |
Why?
| | Myocardium | 1 | 2008 | 911 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2018 | 801 | 0.050 |
Why?
| | Male | 9 | 2021 | 55396 | 0.050 |
Why?
| | Mice, Transgenic | 3 | 2014 | 1947 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 102 | 0.050 |
Why?
| | Ventricular Pressure | 2 | 2012 | 39 | 0.050 |
Why?
| | Infusion Pumps | 1 | 2021 | 31 | 0.050 |
Why?
| | Placental Circulation | 1 | 2021 | 56 | 0.050 |
Why?
| | Down-Regulation | 2 | 2014 | 594 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 154 | 0.050 |
Why?
| | Placentation | 1 | 2021 | 40 | 0.050 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 58 | 0.040 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 63 | 0.040 |
Why?
| | Fetal Weight | 1 | 2021 | 52 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2021 | 146 | 0.040 |
Why?
| | Organ Size | 1 | 2021 | 434 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 1958 | 0.040 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2010 | 56 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 4680 | 0.040 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2018 | 23 | 0.040 |
Why?
| | Aging | 1 | 2008 | 1611 | 0.040 |
Why?
| | Swine | 2 | 2010 | 687 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2010 | 2159 | 0.040 |
Why?
| | Heart Ventricles | 2 | 2014 | 723 | 0.040 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 281 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2018 | 312 | 0.030 |
Why?
| | Stroke Volume | 2 | 2010 | 513 | 0.030 |
Why?
| | Heart Rate | 2 | 2010 | 710 | 0.030 |
Why?
| | Arteries | 1 | 2018 | 246 | 0.030 |
Why?
| | Echocardiography | 2 | 2010 | 569 | 0.030 |
Why?
| | Microglia | 1 | 2017 | 198 | 0.030 |
Why?
| | Mice | 4 | 2014 | 14843 | 0.030 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 151 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2016 | 218 | 0.030 |
Why?
| | Reproduction | 1 | 2016 | 176 | 0.030 |
Why?
| | Homeobox Protein Nkx-2.5 | 1 | 2014 | 4 | 0.030 |
Why?
| | Phenotype | 2 | 2014 | 2784 | 0.030 |
Why?
| | Disease Progression | 2 | 2012 | 2371 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2013 | 2764 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 46 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 229 | 0.030 |
Why?
| | Neuropeptides | 1 | 2014 | 63 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 250 | 0.030 |
Why?
| | Cell Cycle | 1 | 2016 | 541 | 0.030 |
Why?
| | Gene Ontology | 1 | 2013 | 46 | 0.030 |
Why?
| | Models, Genetic | 1 | 2016 | 559 | 0.030 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2012 | 19 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 2013 | 72 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 77 | 0.030 |
Why?
| | Ubiquitin | 1 | 2012 | 57 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2014 | 294 | 0.030 |
Why?
| | Lymphocytes | 1 | 2014 | 327 | 0.030 |
Why?
| | Culture Media | 1 | 2012 | 155 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 133 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 796 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2014 | 371 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 297 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2016 | 572 | 0.020 |
Why?
| | Macrophages | 1 | 2017 | 1259 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 1981 | 0.020 |
Why?
| | Calcium Chloride | 1 | 2010 | 14 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2014 | 518 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2010 | 151 | 0.020 |
Why?
| | Diastole | 1 | 2010 | 137 | 0.020 |
Why?
| | Thoracotomy | 1 | 2010 | 73 | 0.020 |
Why?
| | Aorta | 1 | 2012 | 388 | 0.020 |
Why?
| | Systole | 1 | 2010 | 176 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2010 | 118 | 0.020 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2010 | 78 | 0.020 |
Why?
| | Angiotensin II | 1 | 2010 | 87 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2783 | 0.020 |
Why?
| | Blood Glucose | 1 | 2018 | 1827 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2010 | 106 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 126 | 0.020 |
Why?
| | Matrix Metalloproteinase 14 | 1 | 2008 | 2 | 0.020 |
Why?
| | Tachycardia, Ventricular | 1 | 2010 | 153 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1558 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2010 | 168 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 771 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 2562 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 924 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 445 | 0.020 |
Why?
| | Electrocardiography | 1 | 2010 | 561 | 0.020 |
Why?
| | Recovery of Function | 1 | 2010 | 573 | 0.020 |
Why?
| | Collagen | 1 | 2008 | 414 | 0.020 |
Why?
| | Fibrosis | 1 | 2008 | 452 | 0.020 |
Why?
| | Humans | 5 | 2021 | 114045 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1757 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1624 | 0.010 |
Why?
| | Tocopherols | 1 | 2003 | 22 | 0.010 |
Why?
| | Retinoid X Receptors | 1 | 2003 | 39 | 0.010 |
Why?
| | Receptors, Retinoic Acid | 1 | 2003 | 49 | 0.010 |
Why?
| | Receptors, Steroid | 1 | 2003 | 46 | 0.010 |
Why?
| | Tretinoin | 1 | 2003 | 122 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 3861 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2003 | 345 | 0.010 |
Why?
| | Paclitaxel | 1 | 2003 | 190 | 0.010 |
Why?
| | Molecular Structure | 1 | 2003 | 434 | 0.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 192 | 0.010 |
Why?
| | Ligands | 1 | 2003 | 556 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 2885 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2003 | 613 | 0.010 |
Why?
| | Antioxidants | 1 | 2003 | 529 | 0.010 |
Why?
| | Protein Binding | 1 | 2003 | 1888 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1311 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 4501 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2003 | 1875 | 0.010 |
Why?
|
|
Chang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|